Prudential Financial’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Buy
415,143
+350,504
+542% +$1.28M ﹤0.01% 1502
2025
Q1
$124K Buy
64,639
+170
+0.3% +$326 ﹤0.01% 2109
2024
Q4
$122K Hold
64,469
﹤0.01% 2131
2024
Q3
$85.1K Buy
64,469
+50,200
+352% +$66.3K ﹤0.01% 2594
2024
Q2
$14.6K Sell
14,269
-23,840
-63% -$24.3K ﹤0.01% 2677
2024
Q1
$69.7K Buy
38,109
+16,000
+72% +$29.3K ﹤0.01% 2562
2023
Q4
$27.4K Sell
22,109
-25,400
-53% -$31.5K ﹤0.01% 2600
2023
Q3
$54.2K Hold
47,509
﹤0.01% 2494
2023
Q2
$43.5K Buy
+47,509
New +$43.5K ﹤0.01% 2546
2022
Q2
Sell
-249,912
Closed -$177K 2658
2022
Q1
$177K Sell
249,912
-381,000
-60% -$270K ﹤0.01% 2519
2021
Q4
$1.43M Sell
630,912
-452,993
-42% -$1.02M ﹤0.01% 1707
2021
Q3
$3.12M Buy
1,083,905
+1,062,864
+5,051% +$3.06M ﹤0.01% 1227
2021
Q2
$80K Buy
21,041
+2,655
+14% +$10.1K ﹤0.01% 2503
2021
Q1
$62K Buy
18,386
+60
+0.3% +$202 ﹤0.01% 2452
2020
Q4
$51K Hold
18,326
﹤0.01% 2409
2020
Q3
$46K Buy
18,326
+6,659
+57% +$16.7K ﹤0.01% 2390
2020
Q2
$158K Buy
+11,667
New +$158K ﹤0.01% 2294
2020
Q1
Sell
-12,760
Closed -$81K 2347
2019
Q4
$81K Buy
12,760
+1,600
+14% +$10.2K ﹤0.01% 2384
2019
Q3
$44K Buy
11,160
+1,143
+11% +$4.51K ﹤0.01% 2384
2019
Q2
$48K Sell
10,017
-12,540
-56% -$60.1K ﹤0.01% 2423
2019
Q1
$185K Sell
22,557
-2,476
-10% -$20.3K ﹤0.01% 2328
2018
Q4
$138K Buy
25,033
+6,673
+36% +$36.8K ﹤0.01% 2281
2018
Q3
$162K Sell
18,360
-410
-2% -$3.62K ﹤0.01% 2355
2018
Q2
$187K Buy
+18,770
New +$187K ﹤0.01% 2350
2017
Q4
Sell
-49,360
Closed -$971K 2329
2017
Q3
$971K Buy
+49,360
New +$971K ﹤0.01% 1844